Natera: Solomon Moshkevich, Alexey Aleshin, John Fesko

Natera promoted Solomon Moshkevich to president of clinical diagnostics. He will lead Natera’s general management team across oncology, women’s health, and organ health. Moshkevich will also be responsible for customer service, clinical trial operations, program management, and regulatory and quality affairs. Alexey Aleshin succeed Moshkevich in the role of GM of oncology and early cancer detection, while continuing as Natera's chief medical officer. John Fesko was promoted to president and chief business officer, overseeing reimbursement strategy and market access, patient operations and experience, marketing and communications, government affairs, business and market development, pharmaceutical services, and international commercial operations and strategy.